US Patent 11219618 Pyridylpyridone compounds
Patent 11219618 was granted and assigned to Sprint Bioscience on January, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 12 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 13 Dec, 2023
Golden AI
Edits made to:
Article (+419 characters)
Article
Patent abstract
The invention provides novel pyridylpyridone compounds of formula (I), pharmaceutical compositions containing such compounds, and methods for using such compounds in treatment of diseases including cancer, type II diabetes, inflammatory disease, autoimmune diseases, neurodegenerative disorders, cardiovascular disorders and viral infections; wherein R1, R2, R3 and X are as defined in the specification.
Edits on 2 Nov, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 15 Oct, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Fredrik Rahm0
Jenny Viklund0
Johan Lindström0
Rickard Forsblom0
Tobias Ginman0
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 5 Oct, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
112196180
Date of Patent
January 11, 2022
0Patent Application Number
166398950
Date Filed
August 23, 2018
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 13 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 11219618 Pyridylpyridone compounds
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11219618
Date of patent
January 11, 2022
Patent application number
16639895
Date Filed
August 23, 2018
Patent primary examiner
Find more entities like US Patent 11219618 Pyridylpyridone compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
